The MEVION S250 Proton Therapy System, which has not yet been cleared by the FDA for clinical use, will be housed in the Kling Center for Proton Therapy. The hospital plans to begin treating patients with the proton accelerator by the end of 2012 and expect to treat more than 200 patients a year.
Related Articles on Hospital Oncology and Proton Therapy:
Northwestern, Northern Illinois Partner With Treatment Center to Study Proton Beam Therapy
How Partnering with a Proton Center Can Boost a Hospital’s Oncology Program
Mayo Clinic Investing $370M on Experimental Cancer Treatment Centers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
